High-volume centres achieve excellent long-term survival and low reoperation rates in mitral valve repair—key findings ...
The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.
MUSCAT: A new $100 million venture capital fund, launched recently in the Middle East by prominent early-stage investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback